Aignostics lance PathoSearch, un moteur de recherche visuel dédié aux cas pathologiques
13-09-2026 11:11 via prnewswire.com

Aignostics lance PathoSearch, un moteur de recherche visuel dédié aux cas pathologiques

Désormais disponible en accès anticipé : La recherche par image permet de retrouver des cas de référence réels et diagnostiqués, provenant de centres de renommée mondiale, couvrant plus de 300 entités diagnostiques. BERLIN et NEW YORK, 13 septembre 2026 /PRNewswire/ -- Aignostics a...
Read more »

PR Public relations news



HYLN Investors Have Opportunity to Lead Hyliion Holdings Corp. Securities Fraud Lawsuit
HYLN Investors Have Opportunity to Lead Hyliion Holdings Corp. Securities Fraud Lawsuit
1 MONTH INVESTOR DEADLINE: UWM Holdings Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit Before October 13, 2026 Deadline, Robbins Geller Rudman & Dowd LLP Announces - UWMC
1 MONTH INVESTOR DEADLINE: UWM Holdings Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit Before October 13, 2026 Deadline, Robbins Geller Rudman & Dowd LLP Announces - UWMC
Insurance Agent Nick Hogan Explains What First-Time Homeowners Often Miss About Homeowners Insurance in HelloNation
Insurance Agent Nick Hogan Explains What First-Time Homeowners Often Miss About Homeowners Insurance in HelloNation
REGN INVESTOR DEADLINE TOMORROW: Regeneron Pharmaceuticals, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit, Robbins Geller Rudman & Dowd LLP Announces
REGN INVESTOR DEADLINE TOMORROW: Regeneron Pharmaceuticals, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit, Robbins Geller Rudman & Dowd LLP Announces
GORGIE INTRODUCES BERRY BURST, BRINGING BOLD BERRY FLAVOR AND IT-GIRL STYLE TO MODERN ENERGY
GORGIE INTRODUCES BERRY BURST, BRINGING BOLD BERRY FLAVOR AND IT-GIRL STYLE TO MODERN ENERGY
Phase III TAISHAN-302 Trial Shows Tam-Peli Significantly Improves Survival in Relapsed Small-Cell Lung Cancer
Phase III TAISHAN-302 Trial Shows Tam-Peli Significantly Improves Survival in Relapsed Small-Cell Lung Cancer
Phase III MAVERICK Trial Supports Brain MRI Surveillance Alone as Standard of Care for Small-Cell Lung Cancer
Phase III MAVERICK Trial Supports Brain MRI Surveillance Alone as Standard of Care for Small-Cell Lung Cancer
Rackspace Technology Deadline: RXT Investors Have Opportunity to Lead Rackspace Technology, Inc. Securities Fraud Lawsuit
Rackspace Technology Deadline: RXT Investors Have Opportunity to Lead Rackspace Technology, Inc. Securities Fraud Lawsuit
GAC AION UT gewinnt den Preis für das beste Außendesign beim Torino Automotive Design Award 2026
GAC AION UT gewinnt den Preis für das beste Außendesign beim Torino Automotive Design Award 2026
L'AION UT de GAC remporte le prix du meilleur design extérieur lors du Torino Automotive Design Award 2026
L'AION UT de GAC remporte le prix du meilleur design extérieur lors du Torino Automotive Design Award 2026
Sacituzumab Govitecan Plus Pembrolizumab Does Not Meet Primary Endpoints in First-Line PD-L1-High Metastatic NSCLC
Sacituzumab Govitecan Plus Pembrolizumab Does Not Meet Primary Endpoints in First-Line PD-L1-High Metastatic NSCLC
Phase III ARTEMIS-008 Trial Shows Risvutatug Rezetecan Significantly Improves Overall Survival in Relapsed Small-Cell Lung Cancer
Phase III ARTEMIS-008 Trial Shows Risvutatug Rezetecan Significantly Improves Overall Survival in Relapsed Small-Cell Lung Cancer
DKS Investors Have Opportunity to Lead DICK'S Sporting Goods, Inc. Securities Fraud Lawsuit
DKS Investors Have Opportunity to Lead DICK'S Sporting Goods, Inc. Securities Fraud Lawsuit
POWTEK Group, Heating Tech Expo 2026 ve Zuchex 2026 Fuarlarında Çok Markalı Üretim Gücünü Sergiliyor
POWTEK Group, Heating Tech Expo 2026 ve Zuchex 2026 Fuarlarında Çok Markalı Üretim Gücünü Sergiliyor
Desktop versie